PMID- 29674171 OWN - NLM STAT- MEDLINE DCOM- 20190215 LR - 20190215 IS - 1873-3360 (Electronic) IS - 0306-4530 (Linking) VI - 92 DP - 2018 Jun TI - A combinatorial modulation of synaptic plasticity in the rat medial amygdala by oxytocin, urocortin3 and estrogen. PG - 95-102 LID - S0306-4530(18)30201-4 [pii] LID - 10.1016/j.psyneuen.2018.04.006 [doi] AB - The medial nucleus of the amygdala (MeA) plays a pivotal role in a variety of mammalian social behaviors. Specifically, activity of the hypothalamic pro-social neuropeptide oxytocin in the MeA was shown to be crucial for social recognition memory. The MeA is also a hub of neuroendocrine activity and expresses a large number of receptors of neuropeptides and hormones. These include oxytocin receptor, estrogen receptor alpha and corticotropin-releasing factor (CRF) receptor type 2 (CRFR2). In a previous study we found that intracerebroventricular (ICV) oxytocin application to anesthetized rats promotes long-term depression (LTD) of the MeA response to electrical stimulation of its main sensory input, the accessory olfactory bulb (AOB). We also reported that this type of synaptic plasticity contributes to long-term social recognition memory. Here we used similar methodology to examine the possibility that various neuromodulators pose a combinatorial effect on synaptic plasticity in the MeA. We found that ICV administration of the CRF-related peptide urocortin3 fifteen minutes before oxytocin, caused long-term potentiation (LTP), via CRFR2 activation. Similarly, ICV administration of 17beta-estradiol forty-five minutes before oxytocin induced LTP, which was blocked by an antagonist of the estrogen receptors alpha and beta. Notably, none of these two neuromodulators had any effect on its own, suggesting that they both turn the oxytocin-mediated synaptic plasticity from LTD to LTP. Finally, we found that application of 17beta-estradiol, forty-five minutes before urocortin3 also caused LTP in the MeA response to AOB stimulation, even without oxytocin application. We suggest that the combinatorial modulation of the bidirectional synaptic plasticity in the AOB-MeA pathway by oxytocin, 17beta-estradiol and urocotin-3 serves to modify social information processing according to the animal's internal state. CI - Copyright (c) 2018 Elsevier Ltd. All rights reserved. FAU - Frankiensztajn, Linoy Mia AU - Frankiensztajn LM AD - Sagol Department of Neurobiology, The Integrated Brain and Behavior Research Center (IBBR), University of Haifa, Haifa 3498838, Israel. FAU - Gur-Pollack, Rotem AU - Gur-Pollack R AD - Sagol Department of Neurobiology, The Integrated Brain and Behavior Research Center (IBBR), University of Haifa, Haifa 3498838, Israel. FAU - Wagner, Shlomo AU - Wagner S AD - Sagol Department of Neurobiology, The Integrated Brain and Behavior Research Center (IBBR), University of Haifa, Haifa 3498838, Israel. Electronic address: shlomow@research.haifa.ac.il. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20180411 PL - England TA - Psychoneuroendocrinology JT - Psychoneuroendocrinology JID - 7612148 RN - 0 (Estrogens) RN - 0 (Receptors, Corticotropin-Releasing Hormone) RN - 0 (Receptors, Oxytocin) RN - 0 (Urocortins) RN - 0 (corticotropin-releasing factor receptor type 2a, rat) RN - 0 (urocortin 3, rat) RN - 50-56-6 (Oxytocin) RN - 9015-71-8 (Corticotropin-Releasing Hormone) SB - IM MH - Amygdala/drug effects MH - Animals MH - Corticomedial Nuclear Complex/physiology MH - Corticotropin-Releasing Hormone/metabolism/*pharmacology MH - Estrogens/metabolism/*pharmacology MH - Long-Term Potentiation/drug effects MH - Male MH - Memory, Long-Term/drug effects MH - Neuronal Plasticity/*drug effects MH - Oxytocin/metabolism/*pharmacology MH - Rats MH - Rats, Sprague-Dawley MH - Receptors, Corticotropin-Releasing Hormone/metabolism MH - Receptors, Oxytocin/metabolism MH - Social Behavior MH - Urocortins/metabolism/*pharmacology OTO - NOTNLM OT - Estrogen OT - Medial amygdala OT - Oxytocin OT - Social recognition memory OT - Synaptic plasticity OT - Urocortin3 EDAT- 2018/04/21 06:00 MHDA- 2019/02/16 06:00 CRDT- 2018/04/21 06:00 PHST- 2018/03/06 00:00 [received] PHST- 2018/04/07 00:00 [revised] PHST- 2018/04/09 00:00 [accepted] PHST- 2018/04/21 06:00 [pubmed] PHST- 2019/02/16 06:00 [medline] PHST- 2018/04/21 06:00 [entrez] AID - S0306-4530(18)30201-4 [pii] AID - 10.1016/j.psyneuen.2018.04.006 [doi] PST - ppublish SO - Psychoneuroendocrinology. 2018 Jun;92:95-102. doi: 10.1016/j.psyneuen.2018.04.006. Epub 2018 Apr 11.